US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,476.68

-3.3748-0.23%

Number of Gainers:4

Number of Losers:15

Number of Flat:1

PE:- -

High:1,493.87

Open:1,479.95

Low:1,472.49

Close:1,480.06

Loading ...

Co-Diagnostics, Inc. Wins Dismissal of Class Action Lawsuit

Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More

Pfizer appoints James List to lead development of obesity medicines

Pfizer names James List Chief Internal Medicine Officer

BRIEF-Pfizer Says James List Joins Co As Chief Internal Medicine Officer

Pfizer -James List Joined the Company as Chief Internal Medicine Officer

THOMSON REUTERS

FDA Nominee Marty Makary Faces The Senate. Will He Toe The RFK Jr. Line?

BRIEF-UK's MHRA Approves Lazertinib For Use With Amivantamab For Non-Small Cell Lung Cancer Treatment

Bitcoin & XRP Traders Are Betting Big on OFFICIALMAGACOIN—Here's Why!

European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading

MT Newswires Live

BUZZ-Moderna falls as Berenberg cuts PT on weak respiratory vaccine outlook

Moderna Shares Down 4.2% After 15.9% Rise on Wednesday; Berenberg Cuts PT to $30 From $33

THOMSON REUTERS

Why Moderna, Inc. (MRNA) Went Up on Wednesday

Warburg Research Reaffirms Their Buy Rating on GFT Technologies (0O2W)

Moderna Down 2.4% Premarket After 15.9% Rise on Wednesday; Berenberg Cuts PT to $30 From $33

THOMSON REUTERS

2 Dow Stocks to Buy Hand Over Fist in March and 1 to Avoid

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/BK4568/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4568"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1476.6809,"timestamp":1741636799999,"preClose":1480.0557,"halted":0,"volume":122544343,"delay":0,"changeRate":-0.00228,"change":-3.374756,"pbRate":4.037358,"amount":7780230232.164505,"amplitude":0.01444,"prevYearClose":1274.8187,"fiveDayClose":1475.2046,"twentyDayClose":1354.9427,"turnoverRate":0.007924,"marketCap":1217033329494.5,"floatMarketCap":1195717640124.5,"peRate":31.999995},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1493.8654,"amplitude":0.01444,"preClose":1480.0557,"low":1472.4934,"pbRate":"4.037358","latestPrice":1476.6809,"volume":122544343,"delay":0,"open":1479.9548,"prevYearClose":1274.8187,"prevWeekClose":1480.0557,"prevMonthClose":1463.5875,"prevQuarterClose":1274.8187,"fiveDayClose":1475.2046,"twentyDayClose":1354.9427,"sixtyDayClose":1302.6017,"secType":"PLATE","market":"US","turnoverRate":0.007924,"peRate":31.999995,"marketCap":1217033329494.5,"floatMarketCap":1195717640124.5,"timestamp":1741636799999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":4,"down":15,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:16,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517648118","title":"Co-Diagnostics, Inc. Wins Dismissal of Class Action Lawsuit","url":"https://stock-news.laohu8.com/highlight/detail?id=2517648118","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517648118?lang=en_us&edition=fundamental","pubTime":"2025-03-07 04:30","pubTimestamp":1741293000,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, March 6, 2025 /PRNewswire/ --Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that on March 4, 2025, the Securities & Governance Litigation Team at BakerHostetler, the legal firm retained to represent the Company, won complete dismissal on summary judgment of a Section 10 securities class action that had been pending against the Company in the United States District Court for the District of Utah. See Gelt Trading, Ltd. v. Co-Diagnostics, Inc. et al., Case No. 2:20-cv-00368-JNP-DBP .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/co-diagnostics-inc-wins-dismissal-203000850.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-inc-wins-dismissal-203000850.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","BK4568","CODX"],"gpt_icon":0},{"id":"2517113483","title":"Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More","url":"https://stock-news.laohu8.com/highlight/detail?id=2517113483","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517113483?lang=en_us&edition=fundamental","pubTime":"2025-03-07 04:00","pubTimestamp":1741291200,"startTime":"0","endTime":"0","summary":"Mergers and acquisitions grabbed the spotlight in the biotech sector this week after Jazz Pharmaceuticals JAZZ announced an agreement to acquire Chimerix CMRX. Meanwhile, other pipeline and regulatory updates were in focus.Shares of clinical-stage biotech Chimerix skyrocketed following an acquisition agreement from Jazz Pharmaceuticals for $8.55 per share in cash, aggregating to nearly $935 million.The offer price reflects an approximately 72% premium based on CMRX’ closing price on Tuesday.The acquisition will add CMRX’s lead pipeline drug, dordaviprone, to Jazz’s pipeline. This drug is currently under review by the FDA under the accelerated approval pathway as a potential treatment for adult and pediatric patients with recurrent H3 K27M-mutant diffuse glioma. A final decision is expected by Aug. 18, 2025.The BLA is based on data from positive SWIFT and ANCHOR trials. SWIFT-1 and -2 showed depemokimab reduced exacerbation and hospitalization rates as an add-on therapy for patients wit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stocks-roundup-cmrx-jazz-200000996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MRNA","LU0289739699.SGD","BK4592","BK4139","LU0306806265.USD","LU0053666078.USD","LU0114720955.EUR","LU0456855351.SGD","LU1066053197.SGD","SG9999001176.USD","BK4588","LU1917777945.USD","LU1883839398.USD","LU2023250504.SGD","SG9999001176.SGD","IE00BN0W2V16.EUR","LU0122379950.USD","BK4583","LU1057294990.SGD","IE00B19Z3B42.SGD","IE00BN0W2T93.GBP","BK4568","IE00BLSP4239.USD","IE00B19Z3581.USD","LU0823416689.USD","GSK","LU0321505868.SGD","SGXZ57979304.SGD","LU2362541273.HKD","BK4532","LU0868494617.USD","BK4501","CMRX","JAZZ","LU1023059063.AUD","LU1066051498.USD","LU0985481810.HKD","SG9999013999.USD","LU0225284248.USD","LU1894683264.USD","BK4533","REGN","LU2362541513.USD","LU1974910355.USD","LU2237438978.USD","BK4581","IE000M9KFDE8.USD","LU1829250122.USD","GSK.UK"],"gpt_icon":1},{"id":"2517917341","title":"Pfizer appoints James List to lead development of obesity medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2517917341","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517917341?lang=en_us&edition=fundamental","pubTime":"2025-03-07 03:10","pubTimestamp":1741288230,"startTime":"0","endTime":"0","summary":"Pfizer appoints James List to lead development of obesity medicines   March 6  - Pfizer PFE.N on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, which includes development of cardiovascular and obesity medicines.       ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nL3N3PP1MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","BK4599","SGXZ57979304.SGD","LU1066051498.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1894683264.USD","LU0234572021.USD","LU1883839398.USD","BK4550","BK4534","LU0456855351.SGD","BK4533","SG9999011175.SGD","BK4588","SG9999001176.SGD","LU0306807586.USD","LU1066053197.SGD","LU1057294990.SGD","LU0321505868.SGD","SG9999013999.USD","IE00BBT3K403.USD","LU0321505439.SGD","SG9999002224.SGD","LU1023059063.AUD","PFE","BK4585","LU0170899867.USD","LU0225284248.USD","IE000M9KFDE8.USD","SG9999002232.USD","LU0058720904.USD","IE00BLSP4452.SGD","LU0985481810.HKD","SG9999001176.USD","BK4007","BK4592","IE0002270589.USD","LU0122379950.USD","SG9999003800.SGD","BK4568","LU0225771236.USD","LU0289739699.SGD","LU1894683348.USD","BK4581","LU0306806265.USD","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2517947791","title":"Pfizer names James List Chief Internal Medicine Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2517947791","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517947791?lang=en_us&edition=fundamental","pubTime":"2025-03-07 03:10","pubTimestamp":1741288225,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) announced that James List has joined the company as Chief Internal Medicine Officer. List will oversee Pfizer’s Internal Medicine port...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pfizer-names-james-list-chief-internal-medicine-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pfizer-names-james-list-chief-internal-medicine-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3581.USD","IE00BLSP4239.USD","SG9999002224.SGD","LU0170899867.USD","BK4588","LU1894683264.USD","LU1023059063.AUD","SG9999011175.SGD","LU1883839398.USD","BK4533","LU0456855351.SGD","LU0225284248.USD","LU0234572021.USD","LU1066053197.SGD","IE00BLSP4452.SGD","LU0321505439.SGD","SG9999001176.SGD","BK4592","IE0002270589.USD","LU1066051498.USD","LU1894683348.USD","SG9999002232.USD","SG9999003800.SGD","BK4007","BK4585","LU1057294990.SGD","LU0225771236.USD","LU0321505868.SGD","PFE","BK4599","BK4534","SG9999013999.USD","BK4568","IE00B19Z3B42.SGD","LU0868494617.USD","LU0058720904.USD","IE00BBT3K403.USD","LU0985481810.HKD","BK4550","LU0306807586.USD","SGXZ57979304.SGD","LU0289739699.SGD","LU0306806265.USD","LU0122379950.USD","SG9999001176.USD","IE000M9KFDE8.USD","BK4581"],"gpt_icon":0},{"id":"2517914731","title":"BRIEF-Pfizer Says James List Joins Co As Chief Internal Medicine Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2517914731","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517914731?lang=en_us&edition=fundamental","pubTime":"2025-03-07 03:03","pubTimestamp":1741287802,"startTime":"0","endTime":"0","summary":"BRIEF-Pfizer Says James List Joins Co As Chief Internal Medicine OfficerMarch 6 (Reuters) - Pfizer Inc PFE.N:PFIZER -JAMES LIST JOINED THE COMPANY AS CHIEF INTERNAL MEDICINE OFFICERSource text: [ID:]Further company coverage: PFE.N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP1KS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BBT3K403.USD","BK4007","BK4550","BK4585","SG9999013999.USD","IE00B19Z3581.USD","LU1894683348.USD","LU0225284248.USD","IE00BLSP4452.SGD","BK4533","LU0306806265.USD","LU0321505439.SGD","LU1057294990.SGD","IE000M9KFDE8.USD","LU1883839398.USD","SG9999003800.SGD","SG9999011175.SGD","LU0122379950.USD","LU0456855351.SGD","LU1894683264.USD","LU0868494617.USD","PFE","SG9999002224.SGD","LU0234572021.USD","LU0058720904.USD","LU0985481810.HKD","BK4534","SG9999002232.USD","SGXZ57979304.SGD","BK4581","BK4592","LU0225771236.USD","LU0170899867.USD","LU1066053197.SGD","BK4588","BK4599","LU1066051498.USD","SG9999001176.USD","IE0002270589.USD","LU0321505868.SGD","BK4568","LU1023059063.AUD","SG9999001176.SGD","LU0306807586.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2517819195","title":"Pfizer -James List Joined the Company as Chief Internal Medicine Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2517819195","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517819195?lang=en_us&edition=fundamental","pubTime":"2025-03-07 03:01","pubTimestamp":1741287711,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP1KS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1066051498.USD","SG9999013999.USD","BK4585","SG9999011175.SGD","BK4533","LU0985481810.HKD","LU1066053197.SGD","SG9999001176.USD","BK4599","LU0058720904.USD","BK4550","IE00BLSP4452.SGD","LU0225771236.USD","LU0456855351.SGD","LU1057294990.SGD","BK4534","BK4007","SG9999002232.USD","LU0225284248.USD","LU1883839398.USD","SG9999003800.SGD","PFE","SG9999002224.SGD","IE0002270589.USD","IE00BBT3K403.USD","BK4592","LU0321505439.SGD","SG9999001176.SGD","BK4568","LU0306806265.USD","LU0321505868.SGD","LU0170899867.USD","BK4581","LU0306807586.USD","LU1894683264.USD","IE00B19Z3B42.SGD","LU0234572021.USD","IE000M9KFDE8.USD","LU1023059063.AUD","LU0122379950.USD","IE00BLSP4239.USD","BK4588","LU1894683348.USD","LU0289739699.SGD","SGXZ57979304.SGD","LU0868494617.USD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2517976911","title":"FDA Nominee Marty Makary Faces The Senate. Will He Toe The RFK Jr. Line?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517976911","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517976911?lang=en_us&edition=fundamental","pubTime":"2025-03-07 02:27","pubTimestamp":1741285667,"startTime":"0","endTime":"0","summary":"A Senate committee will vote Thursday on whether to endorse Dr. Marty Makary as the new commissioner of the Food and Drug Administration.","market":"fut","thumbnail":"https://www.investors.com/wp-content/uploads/2017/10/Stock-FDA-Shutterstock-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2017/10/Stock-FDA-Shutterstock-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/news/technology/marty-makary-fda-commissioner-senate-confirmation-biotech-stocks/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["BK4581","IE00BJJMRY28.SGD","LU0868494617.USD","LU1430594728.SGD","IE00BJJMRX11.SGD","LU0417517546.SGD","LU0868494708.USD","LU1244550577.SGD","BK4504","LU0256863811.USD","BK4585","LU1244550494.USD","BK4209","BK4534","BK4566","IE00BJTD4V19.USD","MRNA","BK4588","BK4139","LU0942090050.USD","BK4532","BK4501","BK4568","LU1244550221.USD","LU1718418525.SGD","IE0004445015.USD","MCD","IE00B7KXQ091.USD","LU1585245621.USD","BK4548","LU2133065610.SGD","IE00BJTD4N35.SGD","IE00BFSS8Q28.SGD","BK4533","BK4551","BK4550","IE00BFSS7M15.SGD"],"gpt_icon":1},{"id":"2517672481","title":"BRIEF-UK's MHRA Approves Lazertinib For Use With Amivantamab For Non-Small Cell Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2517672481","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517672481?lang=en_us&edition=fundamental","pubTime":"2025-03-07 00:37","pubTimestamp":1741279078,"startTime":"0","endTime":"0","summary":"BRIEF-UK's MHRA Approves Lazertinib For Use With Amivantamab For Non-Small Cell Lung Cancer TreatmentMarch 6  - UK's MHRA:UK'S MHRA: LAZERTINIB APPROVED FOR USE IN COMBINATION WITH AMIVANTAMAB FOR TREATMENT OF ADULTS WITH NON-SMALL CELL LUNG CANCERFurther company coverage: JNJ.N ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP1KF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1196500208.SGD","LU1935042991.SGD","LU2129689605.HKD","LU1066051225.USD","LU2129689514.USD","LU2129689431.USD","IE00BJJMRZ35.SGD","LU1244550494.USD","SG9999002232.USD","LU0345769128.USD","IE00BVYPNV92.GBP","LU2505996509.AUD","LU1023059063.AUD","IE00B3PB1722.GBP","LU0792757196.USD","LU1914381329.SGD","BK4568","LU1066053197.SGD","LU1674673691.USD","LU2089984988.USD","JNJ","SG9999001440.SGD","IE00BDGV0183.EUR","LU0795875169.SGD","LU0345770993.USD","LU2347655156.SGD","BK4504","IE0009355771.USD","IE00B7SZLL34.SGD","LU0320765646.SGD","LU1032466523.USD","LU1929549753.HKD","LU1057294990.SGD","BK4534","LU0203345920.USD","LU1894683264.USD","LU0345769631.USD","LU1032955483.USD","IE00B1BXHZ80.USD","LU1585245621.USD","SG9999002224.SGD","IE00BGHQF631.EUR","IE000M9KFDE8.USD","LU1674673428.USD","BK4007","BK4532","LU1061106388.HKD","LU2602419157.SGD","BK4588","BK4550"],"gpt_icon":0},{"id":"2517916076","title":"Bitcoin & XRP Traders Are Betting Big on OFFICIALMAGACOIN—Here's Why!","url":"https://stock-news.laohu8.com/highlight/detail?id=2517916076","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517916076?lang=en_us&edition=fundamental","pubTime":"2025-03-07 00:34","pubTimestamp":1741278879,"startTime":"0","endTime":"0","summary":"As the cryptocurrency market evolves in 2025, Bitcoin and XRP traders are turning their attention to OFFICIALMAGACOIN, a new player that's generating significant excitement. Here's why this token is attracting interest from seasoned crypto investors:. OFFICIALMAGACOIN : Incredible Growth Potential – Are You Watching This Coin. OFFICIALMAGACOIN has raised an impressive $4 million during its presale phase, signaling strong investor confidence. This rapid fundraising demonstrates the token's appeal and potential for growth.OFFICIALMAGACOIN is only available through its official website. This exclusivity, combined with a capped supply of 100 billion tokens, creates scarcity that could drive long-term value.Bitcoin : Trading at $90,092.40, up 3.27% in the last 24 hours. XRP: Currently at $2.488, showing a 1.34% increase. Aptos : At $6.02, showing a significant 10.27% increase. Kaspa : Trading at $0.075193, with a minor decrease of 0.63%. Early-Stage Opportunity: Unlike established cryptocur","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/67c9cea14e1e743a780e1743/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["BTC.USD.HKCC","SOL.USD.HKCC","ETH.USD.HKCC","BK4594","BTC","BK4519","BK4086","SOL","BK4568","APT.USD.HKCC","BK4585","APT","APT.USD.CC","BTC.USD.CC","IBIT","BK4129","ETH","BK4588","BK4601"],"gpt_icon":0},{"id":"2517316249","title":"European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2517316249","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517316249?lang=en_us&edition=fundamental","pubTime":"2025-03-07 00:12","pubTimestamp":1741277533,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, declining 0.61% to 1,444.24 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by Sequans Communications  and financial services company ING Groep , which rose 6.8% and 4.2% respectively. They were followed by financial services company Banco Santander  and biopharmaceutical company Genfit , which were up 2.2% each.The decliners from continental Europe were led by furniture maker Natuzzi  and pharmaceutical company Novo Nordisk , which fell 3.7% and 2.1% respectively. They were followed by biotech firm BioNTech  and biopharmaceutical company Cellectis , which lost 1.9% and 1.3% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical companies TC Biopharm  and Akari Therapeutics , which advanced 16.7% and 8.8% respectively. They were followed by communications company WPP  and biopharmaceutical company Verona Pharma , which i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","IE00BKVL7J92.USD","LU1093756168.USD","SAN.AU","LU1093756325.SGD","BK4532","BK4599","IE00BZ1G4Q59.USD","PSO","IHG","BK4207","VRNA","BNTX","SQNS","BK4117","BK4007","BK4551","SAN","ADAP","CLLS","BK7141","CUK","BK4521","AFG","GNFT","BK7505","TCBP","BK4568","ING.AU","NVO.AU","NTZ","WPP","BK4142","BK7142","BK4548","BK4111","BK4204","BK7104","BK4095","BK4139","BK4009","NVO","BK4107","ING","BK4588","AKTX","WPP.AU","LU0154236417.USD","BK4141","BK4535"],"gpt_icon":1},{"id":"2517649701","title":"BUZZ-Moderna falls as Berenberg cuts PT on weak respiratory vaccine outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2517649701","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517649701?lang=en_us&edition=fundamental","pubTime":"2025-03-06 23:45","pubTimestamp":1741275927,"startTime":"0","endTime":"0","summary":"BUZZ-Moderna falls as Berenberg cuts PT on weak respiratory vaccine outlook** Vaccine maker Moderna's MRNA.O shares down 4.3% at $33.71** Brokerage Berenberg cuts PT to $30 from $33, maintains rating to \"hold\"** The new PT represents 14.7% downside to stock's last close on Wednesday** Berenberg sees multiple headwinds for MRNA which include a poor commercial outlook for its respiratory vaccines, and an unsupportive U.S. political environment** Sanofi's SASY.PA entry into the COVID-19 market with the Novavax NVAX.O vaccine will increase pricing pressure and reduce MRNA's market share, brokerage says** \"Moderna will not meet its guidance to break even by 2028 on our forecasts,\" brokerage adds** Two brokerages rate stock \"buy\" or higher, seven \"hold\" or equivalent, and one \"underperform\"; their median PT is $54.51, according to data compiled by LSEG** MRNA has fallen 63.2% in the past 12 months  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nL3N3PP1BC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4532","BK4501","BK4534","MRNA","BK4533","BK4568","BK4548","NVAX","BK4139","BK4551","BK4547"],"gpt_icon":1},{"id":"2517163025","title":"Moderna Shares Down 4.2% After 15.9% Rise on Wednesday; Berenberg Cuts PT to $30 From $33","url":"https://stock-news.laohu8.com/highlight/detail?id=2517163025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517163025?lang=en_us&edition=fundamental","pubTime":"2025-03-06 22:38","pubTimestamp":1741271935,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nL3N3PP194:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4551","BK4501","BK4533","BK4139","BK4585","BK4568","MRNA","BK4534","BK4548","BK4588","BK4532"],"gpt_icon":0},{"id":"2517154712","title":"Why Moderna, Inc. (MRNA) Went Up on Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2517154712","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517154712?lang=en_us&edition=fundamental","pubTime":"2025-03-06 20:55","pubTimestamp":1741265713,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Stocks Lead Wednesday's Charge, Mirror Broader Gains.In this article, we are going to take a look at where Moderna, Inc.  stands against the other stocks.US shares stayed firmer on Wednesday, with all major indices finally eking out gains as President Donald Trump softened on trade restrictions for three large automakers, reviving hopes that the trade war may not be as bad as it seemed.Moderna, Inc.  shares rose for a second day on Wednesday, adding 15.94 percent to finish at $35.21 apiece as investors gobbled up shares in the company following an announcement that it anticipates the release of a personalized cancer vaccine, which it was developing with Merck Co., by 2027.At present, the company is conducting a late-stage trial for a skin cancer vaccine, which, according to Moderna, Inc.  President Stephen Hogek, could rapidly realize revenues.Last month, Moderna, Inc.  also surged following news that a new bat coronavirus carries the risk of anima","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-moderna-inc-mrna-went-125513227.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4501","MNQmain","BK4139",".IXIC","BK4532","TSYW.SI","BK4551","TQQQ","USJW.SI","PSQ","BK4588","BK4533","MRNA","NVIW.SI","USAW.SI","BK4568","NQmain","SQQQ","QID","BK4534","QLD","BK4585","BK4548"],"gpt_icon":1},{"id":"2517153522","title":"Warburg Research Reaffirms Their Buy Rating on GFT Technologies (0O2W)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517153522","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517153522?lang=en_us&edition=fundamental","pubTime":"2025-03-06 19:10","pubTimestamp":1741259431,"startTime":"0","endTime":"0","summary":"In a report released today, Andreas Wolf from Warburg Research maintained a Buy rating on GFT Technologies (0O2W – Research Report), with a price t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/warburg-research-reaffirms-their-buy-rating-on-gft-technologies-0o2w-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/warburg-research-reaffirms-their-buy-rating-on-gft-technologies-0o2w-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BNTX","BK4568","BK4548","BK4139","BK4535","BK4551"],"gpt_icon":0},{"id":"2517131532","title":"Moderna Down 2.4% Premarket After 15.9% Rise on Wednesday; Berenberg Cuts PT to $30 From $33","url":"https://stock-news.laohu8.com/highlight/detail?id=2517131532","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517131532?lang=en_us&edition=fundamental","pubTime":"2025-03-06 17:24","pubTimestamp":1741253049,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nL3N3PP0QX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4548","BK4551","BK4534","BK4139","BK4532","BK4585","MRNA","BK4501","BK4588","BK4533","BK4568"],"gpt_icon":0},{"id":"2517139584","title":"2 Dow Stocks to Buy Hand Over Fist in March and 1 to Avoid","url":"https://stock-news.laohu8.com/highlight/detail?id=2517139584","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517139584?lang=en_us&edition=fundamental","pubTime":"2025-03-06 16:06","pubTimestamp":1741248360,"startTime":"0","endTime":"0","summary":"Two of the Dow Jones Industrial Average's 30 components make for no-brainer buys, while another brand-name member continues to suffer from self-inflicted wounds.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/06/2-dow-stocks-buy-hand-over-fist-march-1-to-avoid/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0965509010.AUD","LU1496350502.SGD","LU0965509101.SGD","LU2112291526.USD","LU0234570918.USD","LU0683600562.USD","LU1814569148.SGD","LU0094547139.USD","LU0211326755.USD","IE00B1BXHZ80.USD","LU0097036916.USD","LU0345770308.USD","IE00B4JS1V06.HKD","LU0820562030.AUD","BK4566","BK4564","GDP","LU0787776722.HKD","LU0965509283.SGD","IE0002141913.USD","IE00BVYPNV92.GBP","LU0203345920.USD","LU2087625088.SGD","BK4568","LU2125154778.USD","IE00BZ9MQY76.HKD","IE00BWXC8680.SGD","LU1064131342.USD","LU2111349929.HKD","LU2089283258.USD","SG9999014906.USD","LU0466842654.USD","BK4213","LU1032466523.USD","LU1267930573.SGD","UNH","IE00B19Z3581.USD","LU0203347892.USD","LU1035773651.USD","BA","LU1551013342.USD","LU2602419157.SGD","LU1548497426.USD","LU0689472784.USD","LU0234572021.USD","LU1267930490.SGD","LU0672654240.SGD","SG9999014898.SGD","JNJ","LU1585245621.USD"],"gpt_icon":1}],"pageSize":16,"totalPage":19,"pageCount":5,"totalSize":300}]}}